Researchers sought to determine whether dapagliflozin could help reverse left ventricular remodeling in patients with type 2 diabetes.
Researchers analyzed the effects of using tolvaptan as add-on therapy for patients hospitalized with acute heart failure.
Through a subanalysis of the REALITY-AHF study, researchers were able to assess the negative effects of an early drop in systolic blood pressure in patients with acute heart failure.
ARNI vs ACE inhibitors or ARB and outcomes in patients with HFrEF.
Study investigators analyzed the effects of MRA cessation on risk-benefit balance of patients with heart failure and hyperkalemia.
Researchers examined the outcomes of GLP-1 receptor agonist therapy in patients with heart failure.